Multidisciplinary management of acute cholecystitis during the COVID-19 pandemic.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
27 Sep 2023
Historique:
received: 08 06 2023
accepted: 25 09 2023
medline: 27 11 2023
pubmed: 28 9 2023
entrez: 27 9 2023
Statut: epublish

Résumé

The coronavirus disease 2019 pandemic had a major impact on most medical services. Our aim was to assess the outcome of acute cholecystitis during the nationwide lockdown period. All patients admitted to our emergency department for AC were analysed. Patient characteristics, performance status, AC severity, treatment modality and outcome of AC were assessed during the lockdown period (Period II: 1 April 2020-30 November 2021) and compared to a historical control period (Period I: 1 May 2017-31 December 2018). AC admissions increased by 72.8% in Period II. Patients were younger (70 vs. 74 years, p = 0.017) and greater in number in the CCI 1 group (20.4% vs. 11.2%, p = 0.043) in Period II. The unplanned readmission rate (6.3 vs. 0%, p = 0.004) and the gallbladder perforation (GP) rate was higher (18.0 vs. 7.3%, p = 0.006) in Period II. Percutaneous transhepatic gallbladder drainage (PTGBD) was more frequent (24.1 vs. 12.8%, p = 0.012) in Period II. In addition to a drop in patient age and CCI, a significant rise in the prevalence of acute cholecystitis, GP and unplanned readmissions was observed during the nationwide lockdown due to the COVID-19 pandemic. PTGBD was more frequent during this period, whereas successful conservative treatment was less frequent.

Identifiants

pubmed: 37759081
doi: 10.1038/s41598-023-43555-3
pii: 10.1038/s41598-023-43555-3
pmc: PMC10533883
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

16257

Informations de copyright

© 2023. The Author(s).

Références

BMC Surg. 2022 May 10;22(1):168
pubmed: 35538571
Front Surg. 2022 Dec 07;9:990533
pubmed: 36570808
Ir J Med Sci. 2022 Feb;191(1):229-232
pubmed: 33704626
BMC Surg. 2021 Apr 6;21(1):180
pubmed: 33823831
J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):55-72
pubmed: 29045062
Cureus. 2022 Jun 22;14(6):e26198
pubmed: 35891865
J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):41-54
pubmed: 29032636
BJS Open. 2022 May 2;6(3):
pubmed: 35511954
J Am Coll Surg. 2023 Jul 1;237(1):87-93
pubmed: 37318137
J Gastrointest Surg. 2022 Jul;26(7):1462-1471
pubmed: 35445322
Int J Surg. 2020 Aug;80:157-161
pubmed: 32679205
Br J Surg. 2020 Aug;107(9):1097-1103
pubmed: 32293715
J Hepatobiliary Pancreat Sci. 2013 Jan;20(1):47-54
pubmed: 23307003
Front Surg. 2022 Apr 12;9:871685
pubmed: 35495756
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716

Auteurs

I Tóth (I)

Department of Surgery, University of Szeged, Szeged, Hungary.

S Ábrahám (S)

Department of Surgery, University of Szeged, Szeged, Hungary.

Z Karamya (Z)

Divison of Gastroenterology, Department of Medicine, University of Szeged, Kálvária Sgt. 57., Szeged, 6725, Hungary.

R Benkő (R)

Department of Clinical Pharmacology, University of Szeged, Szeged, Hungary.

M Matuz (M)

Department of Clinical Pharmacology, University of Szeged, Szeged, Hungary.

A Nagy (A)

Department of Radiology, University of Szeged, Szeged, Hungary.

D Váczi (D)

Department of Surgery, University of Szeged, Szeged, Hungary.

A Négyessy (A)

Department of Surgery, University of Szeged, Szeged, Hungary.
Department of Urology, University of Szeged, Szeged, Hungary.

B Czakó (B)

Divison of Gastroenterology, Department of Medicine, University of Szeged, Kálvária Sgt. 57., Szeged, 6725, Hungary.

D Illés (D)

Divison of Gastroenterology, Department of Medicine, University of Szeged, Kálvária Sgt. 57., Szeged, 6725, Hungary.

M Tajti (M)

Divison of Gastroenterology, Department of Medicine, University of Szeged, Kálvária Sgt. 57., Szeged, 6725, Hungary.

E Ivány (E)

Divison of Gastroenterology, Department of Medicine, University of Szeged, Kálvária Sgt. 57., Szeged, 6725, Hungary.

G Lázár (G)

Department of Surgery, University of Szeged, Szeged, Hungary.

László Czakó (L)

Divison of Gastroenterology, Department of Medicine, University of Szeged, Kálvária Sgt. 57., Szeged, 6725, Hungary. czako.laszlo@med.u-szeged.hu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH